Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Share this content:

Ipilimumab and GMCSF Immunotherapy for Prostate Cancer

Sponsors and Collaborators
University of California, San Francisco
Bristol-Myers Squibb
Sanofi

Contact
Paula Dutton
415-885-7871
walshp@medicine.ucsf.edu

Principal Investigator
Lawrence Fong, MD, University of California, San Francisco

ClinicalTrials.gov Identifier
NCT01530984

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters